In conclusion, Our results suggest that LbGP can be used as an alternative drug to inhibit glioma proliferation, we speculate that LbGP suppresses the expression of SREBP1c by up-regulating Per2, thus inhibiting lipid synthesis and metabolism in gliomas. This evidence concerns the gene SREBF1 and glioma.